In other models of CKD such as cisplatin‐induced kidney injury in mice (Li et al., 2019), angiotensin II‐mediated renal fibrosis in mice (Shen et al., 2016), cadmium‐induced CKD in mice (Dong et al., 2023), streptozotocin‐induced diabetic nephropathy in rats (Nogueira et al., 2018), and diabetic nephropathy in fatty rats (Lee et al., 2016), IFTA was also reduced in animals treated with NAC. Here, AGT is linked to chronic kidney disease.